title: Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay.
abstract: Dendritic cells (DC) from distinct DC subsets are essential contributors to normal human immune responses. Despite this, reliable assays that enable DC to be counted precisely have been slow to evolve. We have now developed a new single-platform flow cytometric assay based on TruCOUNT beads and the whole blood "Lyse/No-Wash" protocol that allows precise counting of the CD14(-) blood DC subsets: CD11c(+)CD16(-) DC, CD11c(+)CD16(+) DC, CD123(hi) DC, CD1c(+) DC and BDCA-3(+) DC. This assay requires 50 microl of whole blood; does not rely on a hematology blood analyser for the absolute DC counts; allows DC counting in EDTA samples 24 h after collection; and is suitable for cord blood and peripheral blood. The data is highly reproducible with intra-assay and inter-assay coefficients of variation less than 3% and 11%, respectively. This assay does not produce the DC-T lymphocyte conjugates that result in DC counting abnormalities in conventional gradient-density separation procedures. Using the TruCOUNT assay, we established that absolute blood DC counts reduce with age in healthy individuals. In preliminary studies, we found a significantly lower absolute blood CD11c(+)CD16(+) DC count in stage III/IV versus stage I/II breast carcinoma patients and a lower absolute blood CD123(hi) DC count in multiple myeloma patients, compared to age-matched controls. These data indicate that scientific progress in DC counting technology will lead to the global standardization of DC counting and allow clinically meaningful data to be obtained.
authors.affiliation: Mater Medical Research Institute, Aubigny Place, Raymond Terrace, South Brisbane, QLD 4101, Australia. svuckovic@mmri.mater.org.au
authors.forename: S
authors.initials: S
authors.lastname: Vuckovic
authors.forename: D
authors.initials: D
authors.lastname: Gardiner
authors.forename: K
authors.initials: K
authors.lastname: Field
authors.forename: G V
authors.initials: GV
authors.lastname: Chapman
authors.forename: D
authors.initials: D
authors.lastname: Khalil
authors.forename: D
authors.initials: D
authors.lastname: Gill
authors.forename: P
authors.initials: P
authors.lastname: Marlton
authors.forename: K
authors.initials: K
authors.lastname: Taylor
authors.forename: S
authors.initials: S
authors.lastname: Wright
authors.forename: A
authors.initials: A
authors.lastname: Pinzon-Charry
authors.forename: C M
authors.initials: CM
authors.lastname: Pyke
authors.forename: R
authors.initials: R
authors.lastname: Rodwell
authors.forename: R L
authors.initials: RL
authors.lastname: Hockey
authors.forename: M
authors.initials: M
authors.lastname: Gleeson
authors.forename: S
authors.initials: S
authors.lastname: Tepes
authors.forename: D
authors.initials: D
authors.lastname: True
authors.forename: A
authors.initials: A
authors.lastname: Cotterill
authors.forename: D N J
authors.initials: DN
authors.lastname: Hart
mesh_terms: D000328:Adult; D000368:Aged; D001772:Blood Cell Count / Q000379:methods; D001943:Breast Neoplasms / Q000097:blood; D002499:Centrifugation, Density Gradient; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood; D015203:Reproducibility of Results